Raymond James downgraded Valens Co from Market Perform to Underperform

Creates a low-cost vertically integrated Canadian company generating over a billion dollars in annualized pro forma revenue1 CALGARY, AB, Jan. 17, 2023 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL" the "Company") is pleased to announce the completion of the previously disclosed acquisition of all of the issued and outstanding common shares ("Valens Shares") of The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) ("Valens"), other than those held by SNDL and its subsidiaries, pursuant to a plan of arrangement under the Canada Business Corporations Act (the "Transaction"), for tota

KELOWNA, BC, Jan. 3, 2023 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) ("The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce today that the Ontario Superior Court of Justice (Commercial List) has granted a final order approving the previously announced plan of arrangement (the "Arrangement") with SNDL Inc. ("SNDL") under Section 192 of the Canada Business Corporations Act in accordance with the terms of the arrangement agreement between Valens and SNDL dated August 22, 2022. Under the terms of the Arrangement

KELOWNA, BC, Dec. 13, 2022 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) (the "Company", "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announced today it received an extension of 180 calendar days from the Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market (the "Bid Price Requirement"), following the expiration of the initial 180 calendar days period to regain compliance on December 12, 2022. The Nasdaq determination is based on the Company meeting the continued listing requirement for mar

ISS highlights that "the arrangement is expected to produce upwards of $15 million of additional EBITDA on an annual run-rate basis through synergies and other strategic initiatives" and that "shareholder approval of arrangement resolution is warranted" Glass Lewis cites the strategic rationale as one of the keys reasons for recommending shareholders vote FOR the Arrangement Shareholders are encouraged to vote well in advance of the proxy deadline of November 25, 2022 at 10:00 a.m. (Toronto time) Shareholders who have questions or need assistance in voting should contact Laurel Hill Advisory Group by telephone at 1-877-452-7184 (North American Toll Free) or 1-416-304-0211 (Outside North Amer

KELOWNA, BC, Nov. 2, 2022 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) (the "Company" or "Valens") (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announced it has received a sales licence amendment from Health Canada for its Pommies manufacturing facility located in the Greater Toronto Area (the "GTA Facility") to sell micro processed cannabis products directly to provincial distributors. Prior to this announcement, Valens leveraged its British Columbia sales licence to sell into the provincial distributors which created additional cost and complexity in our supply chain. With this amendment now in place, products produced a

Valens Shareholders will receive 0.3334 SNDL shares per Valens share, representing a premium of approximately 48% on the 10-day VWAP of the Valens shares on the TSX prior to the signing of a non-binding expression of interest related to the transaction Shareholders are encouraged to vote well in advance of the proxy deadline of November 25, 2022 at 10:00 a.m. (Toronto time) Shareholders who have questions or need assistance in voting should contact Laurel Hill Advisory Group by telephone at 1-877-452-7184 (North American Toll Free) or 1-416- 304-0211 (Outside North America), or by email at [email protected] KELOWNA, BC, Oct. 27, 2022 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS)

Cash flow from operations improved by $12.2 million quarter-over-quarter, exceeding previous guidance Continued to realize the benefits of Integration Initiatives, with adjusted gross margin(1) expanding to 24.9% of net revenue in Q3 2022 compared to 17.2% of net revenue in Q2 2022 and SG&A declining 28.6% in Q3 2022 from Q2 2022 Provincial sales rebounded strongly in Q3 2022 with net sales increasing 22.8% to a record $11.3 million from $9.2 million in Q2 2022 Top 10 licensed producer in Canada, with a 3.4% market share for the month of August 2022(3) Entered into an arrangement agreement to be acquired by SNDL, creating a leading vertically integrated entity with the highest pro forma cann

KELOWNA, BC, Oct. 6, 2022 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) (the "Company" "The Valens Company" or "Valens") a leading manufacturer of cannabis products, is pleased to announce it will issue its third quarter 2022 financial results for the period ended August 31, 2022, on Thursday, October 13, 2022, before market open. About The Valens Company The Valens Company is a leading manufacturer of cannabis products with a mission to bring the benefits of cannabis to the world. The Company provides proprietary cannabis processing services, in addition to

CALGARY, AB and KELOWNA, BC, Aug. 22, 2022 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL") and The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) ("Valens") are pleased to announce today that they have entered into an arrangement agreement (the "Agreement") to combine their businesses and create a leading vertically integrated cannabis platform. Pursuant to the terms of the Agreement, SNDL will acquire all of the issued and outstanding common shares of Valens ("Valens Shares"), other than those owned by SNDL and its subsidiaries, by way of a statutory plan of arrangement (the "Transaction"). All financial information in this press release is reported in Canadian dollars unless otherwise indica

KELOWNA, BC, Aug. 3, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (NASDAQ:VLNS) (the "Company", "The Valens Company" or "Valens") a leading manufacturer of cannabis products, today announced the voting results from its Annual General Meeting of Shareholders (the "Meeting"), held by way of live audio webcast on August 2, 2022. Six of the director nominees that were put forward by the Company were elected by shareholders at the Meeting to hold office until the next annual meeting of shareholders or until their successors are elected or appointed. The results of the vo

KELOWNA, BC, May 16, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS)) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of branded cannabis products, today announced that it has separated the roles of Chair and Chief Executive Officer (CEO) and appointed Andrew Cockwell as its new Chair of the Board, effective immediately.  This decision follows the Company's recent Nasdaq listing and its commitment to governance best practices including transparency and accountability. Tyler Robson has stepped down as Chair in full support of this decision and will remain on the Board and as the CEO of the Company.

HOD HASHARON, Israel,, July 20, 2022 /PRNewswire/ -- Valens Semiconductor (NYSE:VLN), a premier provider of high-speed connectivity solutions for the audio-video and automotive markets, today announced that it will release its second quarter 2022 financial results before the market opens on Wednesday, August 10, 2022. In conjunction with this announcement, Valens will host a conference call on Wednesday, August 10, 2022, at 8:30 a.m. Eastern Time (ET) to discuss its second quarter 2022 financial results and business outlook. To access this call, dial +1 (888) 642-5032 (U.S.), 0 (800) 917-5108 (UK), 03 918 0609 (Israel) or +972 3 918 0609 (all other locations). A live webcast of the conferenc

Realized initial benefits of Integration Initiatives, with SG&A as a percent of revenue declining 908 basis points in Q2 2022 from Q1 2022 In five months, Valens has actioned $15 million in annual cost savings and has identified in excess of $5 million additional cost savings to be actioned over the next few quarters exceeding management's original $20 million target Achieved double-digit revenue growth in Green Roads, B2B, & International revenue segments. Provincial sales rebounded strongly in June with record monthly revenue Top 10 licensed producer in Canada, with a 3.2% market share for three months ending May 2022 Valens reiterates its objective of achieving positive adjusted EBITDA(2

KELOWNA, BC, July 6, 2022 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce it will issue its second quarter 2022 financial results for the period ended May 31, 2022, on Wednesday, July 13, 2022, after market close. CONFERENCE CALL DETAILS The Company will host a conference call the following day, Thursday, July 14, 2022, at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time to discuss the financial results and business outlook. Participant Dial-In

KELOWNA, BC, April 7, 2022 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce it will issue its first quarter 2022 financial results for the period ended February 28, 2022, on Wednesday, April 13, 2022, after market close. CONFERENCE CALL DETAILSThe Company will host a conference call the following day, Thursday, April 14, 2022, at 11:00 AM Eastern Time / 8:00 AM Pacific Time to discuss the financial results and business outlook. Participant Dial-I

Provincial sales net revenue increased 31.7% to $7.9 million in Q4 2021 compared to $6.0 million in Q3 2021 Canada-wide provincial listings increased 21.0% to 219 in Q4 2021, compared to 181 in Q3 2021, with further growth to 255 as of January 30, 2022 Adjusted gross profit margin increased significantly to 34.1% in Q4 2021 compared to 27.4% in Q3 2021 B2C revenue lines of provincial sales and Green Roads accounted for 73.9% of net revenue in Q4 2021 Valens expects to achieve positive adjusted EBITDA by Q4 2022 KELOWNA, BC, Feb. 28, 2022 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) (the "Company", "The Valens Company" or "Valens"), a leading manufacturer of cannabis produ

KELOWNA, BC, Feb. 17, 2022 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce it will issue its fourth quarter and fiscal year 2021 financial results for the period ended November 30, 2021, on Monday, February 28, 2022, after market close. CONFERENCE CALL DETAILS The Company will host a conference call the following day, Tuesday, March 1, 2022 at 11:00 am Eastern Time / 8:00 am Pacific Time to discuss the financial results and business outlook. Par

15-12G - Valens Company, Inc. (0001859902) (Filer)

F-10POS - Valens Company, Inc. (0001859902) (Filer)

6-K - Valens Company, Inc. (0001859902) (Filer)

25-NSE - Valens Company, Inc. (0001859902) (Subject)

6-K - Valens Company, Inc. (0001859902) (Filer)

6-K - Valens Company, Inc. (0001859902) (Filer)

6-K - Valens Company, Inc. (0001859902) (Filer)

6-K - Valens Company, Inc. (0001859902) (Filer)

6-K - Valens Company, Inc. (0001859902) (Filer)

6-K - Valens Company, Inc. (0001859902) (Filer)